Back
Appili Therapeutics, Inc. 10K Form
Sell
29
APLIF
Appili Therapeutics, Inc.
Last Price:
$0.0112
Seasonality Move:
-31.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive APLIF News And Ratings
See the #1 stock for the next 7 days that we like better than APLIF
APLIF Financial Statistics
Sales & Book Value
| Annual Sales: | $72.2K |
|---|---|
| Cash Flow: | $-202.8K |
| Price / Cash Flow: | 3.29 |
| Annual Sales: | $-0.09 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.01720 |
|---|---|
| Net Income (TTM): | $-2.1M |
| Gross Margin: | $62.5K |
| Return on Equity: | 0% |
| Return on Assets: | -181.18% |
Appili Therapeutics, Inc. Earnings Forecast
Key Appili Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 4 years for APLIF is 86.57%.
-
The Selling, General & Administrative Expenses for APLIF have been equal to 2,841.14% of Gross Profit Margin.
-
The Research & Development expenses have been 7,303.32% of Revenue.
-
The Net Earning history of APLIF is -2,613.57% of Total Revenues.
-
Per Share Earnings over the last 8 years have been positive in 3 years.
Appili Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | APLIF |
| Website: | appilitherapeutics.com |
Debt
| Debt-to-Equity Ratio: | -0.76 |
|---|---|
| Current Ratio: | 0.03 |
| Quick Ratio: | 0.01 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
APLIF Technical Analysis vs Fundamental Analysis
Sell
29
Appili Therapeutics, Inc. (APLIF)
is a Sell
Is Appili Therapeutics, Inc. a Buy or a Sell?
-
Appili Therapeutics, Inc. stock is rated a SellThe current Appili Therapeutics, Inc. [APLIF] share price is $0.0112. The Score for APLIF is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.